Evidence map›Paper›PMID 23725359›Full record

Observational studyThe American journal of managed care2013

More comprehensive discussion of CRC screening associated with higher screening.

David M Mosen, Adrianne C Feldstein, Nancy A Perrin, A Gabriella Rosales, David H Smith, Elizabeth G Liles, Jennifer L Schneider, Ronald E Meyers, Jennifer Elston-Lafata

Registry-linked trialOpen access · greenAbstract readObservational Study
In one paragraph

Observational study in The American journal of managed care, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06182475 (Increasing Equity in Live Donor Kidney Transplantation Through Effective Patient-Provider Communication), which is not on this map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06182475 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Increasing Equity in Live Donor Kidney Transplantation Through Effective Patient-Provider Communication

TypeinterventionalSponsorTemple UniversityRan2026 to 2027Enrolled70ConditionsKidney Disease, Chronic, End Stage Renal Disease, Kidney ReplacementArmsEPPComm Provider Training
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Epigenetic Biomarkers in Colorectal Cancer.Molecular diagnosis & therapy · 2017
    Review
  10. Screening for colorectal cancer: the role of the primary care physician.European journal of gastroenterology & hepatology · 2017
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

David M MosenCenter for Health Research, Kaiser Permanente Northwest, Portland, OR, USA.
Adrianne C Feldstein
Nancy A Perrin
A Gabriella Rosales
David H Smith
Elizabeth G Liles
Jennifer L Schneider
Ronald E Meyers
Jennifer Elston-Lafata
Kaiser Permanente Center for Health Research · US

Funding

Focusing Implementation to Bring Effective Reminders: FIBERR01CA132709 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI FELDSTEIN, ADRIANNE C · 2008 to 2011
$2.3M
NCI NIH HHS R01 CA132709NCI NIH HHS R01CA132709
6 · The paper itself

Abstract

objectivesExamine association of comprehensiveness of colorectal cancer (CRC) screening discussion by primary care physicians (PCPs) with completion of CRC screening. STUDY

designObservational study in Kaiser Permanente Northwest, a group-model health maintenance organization.

methodsA total of 883 participants overdue for CRC screening received an automated telephone call (ATC) between April and June 2009 encouraging CRC screening. Between January and March 2010, participants completed a survey on PCPs' discussion of CRC screening and patient beliefs regarding screening. PRIMARY OUTCOME MEASURE: receipt of CRC screening (assessed by electronic medical record [EMR], 9 months after ATC). Primary independent variable: comprehensiveness of CRC screening discussion by PCPs (7-item scale). Secondary independent variables: perceived benefits of screening (4-item scale assessing respondents' agreement with benefits of timely screening) and primary care utilization (EMR; 9 months after ATC). The independent association of variables with CRC screening was assessed with logistic regression.

resultsAverage scores for comprehensiveness of CRC discussion and perceived benefits were 0.4 (range 0-1) and 4.0 (range 1-5), respectively. A total of 28.2% (n = 249) completed screening, 84% of whom had survey assessments after their screening date. Of screeners, 95.2% completed the fecal immunochemical test. More comprehensive discussion of CRC screening was associated with increased screening (odds ratio [OR] = 1.51, 95% confidence interval [CI] = 1.03-2.21). Higher perceived benefits (OR = 1.46, 95% CI = 1.13-1.90) and 1 or more PCP visits (OR = 5.82, 95% CI = 3.87-8.74) were also associated with increased screening.

conclusionsMore comprehensive discussion of CRC screening was independently associated with increased CRC screening. Primary care utilization was even more strongly associated with CRC screening, irrespective of discussion of CRC screening.

Indexed as

Referral and ConsultationAgedAged, 80 and overColorectal NeoplasmsFemaleHealth Maintenance OrganizationsHumansMaleMass ScreeningMiddle AgedOregonPhysician-Patient RelationsPhysicians, Primary CareReminder Systems

Identifiers

PMID23725359
PMCPMC3891849
OpenAlexW1828630024

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.